Yeshong PARK
Role of Minimally Invasive Approach in Reoperation for Postoperatively Diagnosed T2 Gallbladder Cancer: a Multicenter Cohort Study
15:30-15:37 / BP OP 1-1
Role of Minimally Invasive Approach in Reoperation for Postoperatively Diagnosed T2 Gallbladder Cancer: a Multicenter Cohort Study
15:30-15:37 / BP OP 1-1
Soo Yeun LIM
Clinicopathological Feature And Impact of Adjuvant Therapy in T1 Pancreatic Ductal Adenocarcinoma: a Single Institutional Retrospective Analysisture
15:37-15:44 / BP OP 1-2
Clinicopathological Feature And Impact of Adjuvant Therapy in T1 Pancreatic Ductal Adenocarcinoma: a Single Institutional Retrospective Analysisture
15:37-15:44 / BP OP 1-2
Seung Soo HONG
Minimally Invasive Pancreatoduodenectomy with Combined Venous Vascular Resection; a Comparative Analysis with Open Approach
15:44-15:51 / LV OP 1-3
Minimally Invasive Pancreatoduodenectomy with Combined Venous Vascular Resection; a Comparative Analysis with Open Approach
15:44-15:51 / LV OP 1-3
Atsushi OBA
Unresectable Pancreatic Cancer Is Not Always “Unresectable” in the Era of Multidisciplinary Treatment: Proposal of ABCD Criteria
15:51-15:58 / BP OP 1-4
Unresectable Pancreatic Cancer Is Not Always “Unresectable” in the Era of Multidisciplinary Treatment: Proposal of ABCD Criteria
15:51-15:58 / BP OP 1-4
Aram SHIN
Exclusive Liver Invasion As a Better Prognostic Indicator in T3 Gallbladder Cancer
15:58-16:05 / BP OP 1-5
Exclusive Liver Invasion As a Better Prognostic Indicator in T3 Gallbladder Cancer
15:58-16:05 / BP OP 1-5
Ning PU
Survival Benefit And Impact of Adjuvant Chemotherapy Following Systemic Neoadjuvant Chemotherapy in Patients with Resected Pancreas Ductal Adenocarcinoma
16:05-16:12 / BP OP 1-6
Survival Benefit And Impact of Adjuvant Chemotherapy Following Systemic Neoadjuvant Chemotherapy in Patients with Resected Pancreas Ductal Adenocarcinoma
16:05-16:12 / BP OP 1-6
Byeong Gwan NOH
Prognostic Impact of Immunohistochemical Expression of MUC in Curatively Resected Ampulla of Vater Cancer
16:12-16:19 / BP OP 1-7
Prognostic Impact of Immunohistochemical Expression of MUC in Curatively Resected Ampulla of Vater Cancer
16:12-16:19 / BP OP 1-7